[ad_1]
Vials of the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting the BA.4 and BA.5 Omicron subvariants at Skippack Pharmacy, Schwenksville, Pennsylvania, USA, September 8, 2022. (Reuters/Hannah Beier)
Canada on Friday approved the latest COVID-19 booster shots targeting Omicron’s BA.4 and BA.5 variants from Pfizer and its partner BioNTech SE, according to the government website.
Pfizer and BioNTech said in a joint statement that the two companies “will make a large batch of the vaccine available in the coming days.”
The booster shot, which is approved for people 12 years and older, is the second shot to be approved by Health Canada, following Moderna Inc’s Modified Booster last month.
Moderna Vaccine Booster is approved for use in adults.
So-called bivalent vaccines target both the original and two Omicron variants.
Pfizer has sought approval from health regulators in the United States and Europe to use Omicron-tailored shots in children ages 5 to 11, and has submitted an application to Health Canada for the same age group. said it was planned.
The U.S. Food and Drug Administration approved the latest COVID-19 booster shots from both Moderna and Pfizer/Biontech in August.
European Union and Japanese regulators have also cleared Pfizer’s updated booster shots.
follow
[ad_2]